Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09VLX
|
|||
| Former ID |
DNC002139
|
|||
| Drug Name |
ISIS 18473
|
|||
| Drug Type |
Antisense drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Company |
Isis Pharmaceuticals
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | FAP-1 messenger RNA (PTPN13 mRNA) | Target Info | . | [1] |
| NetPath Pathway | TGF_beta_Receptor Signaling Pathway | |||
| Pathway Interaction Database | Fc-epsilon receptor I signaling in mast cells | |||
| Ephrin B reverse signaling | ||||
| WikiPathways | Ectoderm Differentiation | |||
| Apoptosis Modulation and Signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | US patent application no. 6,204,055, Antisense inhibition of Fas mediated signaling. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.